Oncology agreement to drive translational research in Spain
This article was originally published in Scrip
The Spanish ministry for science and innovation and the autonomous community of Madrid have signed an oncology R&D collaboration protocol that should be a boon for translational research.
You may also be interested in...
Insurers argue that better use of real world data and multiple pricing assessments could help lower drug prices in Germany.
To keep investors happy, companies will have to start showing that their high-priced advanced therapies offset costs elsewhere in the health care system.
To maintain high prices and avoid access restrictions, companies marketing advanced therapies will have to show payers that their products save money elsewhere in the healthcare system.